Diamond Hill Capital Management’s Elevance Health ELV Stock Holding History

Diamond Hill Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$96.6M	Buy	+249,722	New	+$92.6M	0.77%	46

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Diamond Hill Capital Management's ELV Position: Q2 2026 in Review

Diamond Hill Capital Management opened a new position in Elevance Health (ELV) in Q2 2026: 249,722 shares worth $96.6M. The stake represents 0.77% of the portfolio and ranks #46 among its holdings.

1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Diamond Hill Capital Management held 249,722 shares of Elevance Health worth $96.6M as of Q2 2026.
Elevance Health was a new Diamond Hill Capital Management position in Q2 2026.
Elevance Health made up 0.77% of Diamond Hill Capital Management's portfolio in Q2 2026, its #46 holding.
1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Diamond Hill Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.